1、S-1/A 1 eps12643_ctth.htm As filed with the U.S.Securities and Exchange Commission on June 16,2026Registration No.333-292497UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_Amendment No.3 toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933_CTT PHARMACEUTICAL HOLDINGS,I
2、NC.(Exact name of registrant as specified in its charter)_ Delaware 2833 11-3763974(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)1646 W Snow Avenue Suite 138Tampa,FL 33606(813)606-0060(Address,
3、including zip code,and telephone number,including area code,of registrants principal executive offices)_Ryan KhouriChief Executive Officer1646 W Snow Avenue Suite 138Tampa,FL 33606(813)606-0060(Name,address,including zip code,and telephone number,including area code,of agent for service)_Please send
4、 copies of all communications to:Frank J.Hariton,Esq.1065 Dobbs Ferry RoadWhite Plains,New York 10607(914)649-7669_Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this registration statement.If any of the securities being registered
5、on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the SecuritiesAct of 1933,check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following box andlist
6、the Securities Act registration statement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and list the Securities Actregistration statement number of